An inhaled medicine for tiny babies' lungs
Official title: Inhaled ciclesonide - a phase I study in preterm infants
Funded at Children's Mercy Hosp (Kansas City, Mo) · NIH-11161516 · Data updated 2026-11-12
This research is exploring a new inhaled medicine called ciclesonide to help protect the lungs of very premature babies.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Mercy Hosp (Kansas City, Mo) NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | August 5, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $195,800 |
| NIH project number | 5R21HD116421-02 |
| Project ID | NIH-11161516 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would be very premature infants born before 30 weeks of gestation.
✕Less likely to help
Patients who are not premature infants or those without risk of bronchopulmonary dysplasia would not receive direct benefit from this specific research.
What this research studies
Very premature babies often develop a serious lung condition called bronchopulmonary dysplasia (BPD), which can lead to long-term breathing problems. While some medicines are currently used to prevent BPD, they can have serious side effects, including affecting brain development. This project is looking at ciclesonide, an inhaled medicine already approved for asthma in older children, to see if it can protect the lungs of premature infants without these harmful side effects. Researchers have seen promising results in lab studies, suggesting it might be as effective as current treatments but much safer for these vulnerable infants.
Why it matters
Potential benefit: If successful, this medicine could offer a safer way to prevent serious lung disease in premature infants, reducing long-term health problems.
How similar studies have gone: While ciclesonide is approved for asthma in older children, its use for preventing lung injury in premature infants is a novel application, with promising results seen in animal models.
Where this research is happening
-
Children's Mercy Hosp (Kansas City, Mo)
Kansas City, United States Active
Researchers
- Principal investigator: Sampath, Venkatesh — Children's Mercy Hosp (Kansas City, Mo)
- Study coordinator: Sampath, Venkatesh
Related research
Other NIH-funded projects on the same topics.
-
Screening and treatment of Chlamydia infection in pregnancy to help prevent preterm birth
This grant studies whether screening pregnant people for Chlamydia trachomatis and treating those who are positive can reduce the risk of preterm birth.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Brain injury risk in preterm babies with heart disease and how surgery choices affect their brains
This project follows newborns with congenital heart disease born early to understand how their brains are affected and how different surgical approaches might influence outcomes.
-
Xylitol to Prevent Periodontal Disease and Preterm Birth in Pregnancy and Early Childhood
A safe, inexpensive chewable gum approach using xylitol is tested to help pregnant people reduce gum disease and lower the chance of preterm birth and related child health problems.
-
Screening and treatment for Chlamydia infection to help prevent preterm birth
A study in pregnant people will test whether screening for Chlamydia trachomatis and treating it during pregnancy can reduce the risk of babies being born too early.
-
PREEMIE PROGRESS: a family program to help parents of very preterm babies
A family-centered program that teaches parents how to care for very preterm infants, offers psychosocial support, and connects families with resources to address social needs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.